journal article·2018-08Open access

Suppressing mesenchymal stem cell hypertrophy and endochondral ossification in 3D cartilage regeneration with nanofibrous poly(l-lactic acid) scaffold and matrilin-3

Qihai Liu, Jun Wang, Yupeng Chen, Zhanpeng Zhang, Laura Saunders, Ernestina Schipani, Qian Chen, Peter X. Ma

Acta Biomaterialia· Volume 76

Abstract

Articular cartilage has a very limited ability to self-heal after injury or degeneration due to its low cellularity, poor proliferative activity, and avascular nature. Current clinical options are able to alleviate patient suffering, but cannot sufficiently regenerate the lost tissue. Biomimetic scaffolds that recapitulate the important features of the extracellular matrix (ECM) of cartilage are hypothesized to be advantageous in supporting cell growth, chondrogenic differentiation, and integration of regenerated cartilage with native cartilage, ultimately restoring the injured tissue to its normal function. It remains a challenge to support and maintain articular cartilage regenerated by bone marrow-derived mesenchymal stem cells (BMSCs), which are prone to hypertrophy and endochondral ossification after implantation in vivo. In the present work, a nanofibrous poly(l-lactic acid) (NF PLLA) scaffold developed by our group was utilized because of the desired highly porous structure, high interconnectivity, and collagen-like NF architecture to support rabbit BMSCs for articular cartilage regeneration. We further hypothesized that matrilin-3 (MATN3), a non-collagenous, cartilage-specific ECM protein, would enhance the microenvironment of the NF PLLA scaffold for cartilage regeneration and maintain the cartilage property. To test this hypothesis, we seeded BMSCs on the NF PLLA scaffold with or without MATN3. We found that MATN3 suppresses hypertrophy in this 3D culture system in vitro. Subcutaneous implantation of the chondrogenic cell/scaffold constructs in a nude mouse model showed that pretreatment with MATN3 was able to maintain chondrogenesis and prevent hypertrophy and endochondral ossification in vivo. These results demonstrate that the porous NF PLLA scaffold treated with MATN3 represents an advantageous 3D microenvironment for cartilage regeneration and phenotype maintenance, and is a promising strategy for articular cartilage repair. Statement of significance Articular cartilage defects, caused by trauma, inflammation, or joint instability, may ultimately lead to debilitating pain and disability. Bone marrow-derived mesenchymal stem cells (BMSCs) are an attractive cell source for articular cartilage tissue engineering. However, chondrogenic induction of BMSCs is often accompanied by undesired hypertrophy, which can lead to calcification and ultimately damage the cartilage. Therefore, a therapy to prevent hypertrophy and endochondral ossification is of paramount importance to adequately regenerate articular cartilage. We hypothesized that MATN3 (a non-collagenous ECM protein expressed exclusively in cartilage) may improve regeneration of articular cartilage with BMSCs by maintaining chondrogenesis and preventing hypertrophic transition in an ECM mimicking nanofibrous scaffold. Our results showed that the administration of MATN3 to the cell/nanofibrous scaffold constructs favorably maintained chondrogenesis and prevented hypertrophy/endochondral ossification in the chondrogenic constructs in vitro and in vivo. The combination of nanofibrous PLLA scaffolds and MATN3 treatment provides a very promising strategy to generate chondrogenic grafts with phenotypic stability for articular cartilage repair.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Electrospun Nanofibers in Biomedical Applications · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (42)

Show source-provided references
1. Cartilage engineering: a crucial combination of cells, biomaterials and biofactors10.1016/j.tibtech.2009.02.005 ↗
2. Controlled release strategies for bone, cartilage, and osteochondral engineering–Part I: recapitulation of native tissue healing and variables for the design of delivery systems10.1089/ten.teb.2012.0138 ↗
3. Tissue engineering10.1126/science.8493529 ↗
4. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice10.1002/art.22136 ↗
5. Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells10.1002/art.23370 ↗
6. Unlike bone, cartilage regeneration remains elusive10.1126/science.1222454 ↗
7. Enhancing and maintaining chondrogenesis of synovial fibroblasts by cartilage extracellular matrix protein matrilins10.1016/j.joca.2007.12.011 ↗
8. Functional knockout of the matrilin-3 gene causes premature chondrocyte maturation to hypertrophy and increases bone mineral density and osteoarthritis10.2353/ajpath.2006.050981 ↗
9. Matrilin-3 inhibits chondrocyte hypertrophy as a bone morphogenetic protein-2 antagonist10.1074/jbc.M114.583104 ↗
10. Matrilin-3 induction of IL-1 receptor antagonist is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression10.1186/ar4033 ↗
11. Biomimetic materials for tissue engineering10.1016/j.addr.2007.08.041 ↗
12. Macroporous and nanofibrous polymer scaffolds and polymer/bone-like apatite composite scaffolds generated by sugar spheres10.1002/jbm.a.30704 ↗
13. The enhancement of human embryonic stem cell osteogenic differentiation with nano-fibrous scaffolding10.1016/j.biomaterials.2010.03.065 ↗
14. Regenerating nucleus pulposus of the intervertebral disc using biodegradable nanofibrous polymer scaffolds10.1089/ten.tea.2011.0747 ↗
15. Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds10.1016/j.biomaterials.2014.07.011 ↗
16. Porous nanofibrous poly(L-lactic acid) scaffolds supporting cardiovascular progenitor cells for cardiac tissue engineering10.1016/j.actbio.2015.08.017 ↗
17. Characterization and differentiation potential of rabbit mesenchymal stem cells for translational regenerative medicine10.1007/s11626-013-9702-5 ↗
18. Injectable peptide decorated functional nanofibrous hollow microspheres to direct stem cell differentiation and tissue regeneration10.1002/adfm.201402618 ↗
19. Chondrogenic and osteogenic differentiations of human bone marrow-derived mesenchymal stem cells on a nanofibrous scaffold with designed pore network10.1016/j.biomaterials.2009.06.013 ↗
20. A comparative study of proliferation and osteogenic differentiation of adipose-derived stem cells on akermanite and beta-TCP ceramics10.1016/j.biomaterials.2008.08.039 ↗
21. Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size10.1089/ten.teb.2012.0437 ↗
22. Nanofibrous hollow microspheres self-assembled from star-shaped polymers as injectable cell carriers for knee repair10.1038/nmat2999 ↗
23. Nanotechnological strategies for engineering complex tissues10.1038/nnano.2010.246 ↗
24. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee10.1302/0301-620X.85B2.13543 ↗
25. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation10.1056/NEJM199410063311401 ↗
26. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial10.2106/00004623-200403000-00001 ↗
27. Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years10.2106/00004623-200300002-00003 ↗
28. Molecular analysis of expansion, differentiation, and growth factor treatment of human chondrocytes identifies differentiation markers and growth-related genes10.1016/S0006-291X(02)00223-1 ↗
29. Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture10.1053/joca.2001.0482 ↗
30. Primary structure of matrilin-3, a new member of a family of extracellular matrix proteins related to cartilage matrix protein (matrilin-1) and von Willebrand factor10.1016/S0014-5793(97)00895-8 ↗
31. Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan10.1074/jbc.M304638200 ↗
32. Shifting HIFs in osteoarthritis10.1038/nm0610-641 ↗
33. Duval · Arthr. Rheum. · 2009 · 60 · 303810.1002/art.24851 ↗
34. Hypoxia-inducible factor 2alpha is essential for hypoxic induction of the human articular chondrocyte phenotype10.1002/art.22878 ↗
35. Wogonoside inhibits IL-1beta induced catabolism and hypertrophy in mouse chondrocyte and ameliorates murine osteoarthritis10.18632/oncotarget.18374 ↗
36. Effects of platelet rich plasma and chondrocyte co-culture on MSC chondrogenesis, hypertrophy and pathological responses
37. Notch signaling in chondrocytes modulates endochondral ossification and osteoarthritis development10.1073/pnas.1207458110 ↗
38. Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB10.1016/j.jconrel.2006.01.011 ↗
39. Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo10.1371/journal.pone.0001729 ↗
40. Dentin regeneration by stem cells of apical papilla on injectable nanofibrous microspheres and stimulated by controlled BMP-2 release10.1016/j.actbio.2016.03.015 ↗
41. The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres10.1016/j.biomaterials.2006.12.028 ↗
42. Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects10.1038/ncomms10376 ↗